- Home
- SUPN vs OSW Comparison
SUPN vs OSW Comparison
Compare SUPN & OSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SUPN | OSW |
|---|---|---|
| Founded | 2005 | 2017 |
| Country | United States | Bahamas |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | SUPN | OSW |
|---|---|---|
| Price | $51.84 | $21.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $61.60 | $24.33 |
| AVG Volume (30 Days) | ★ 690.1K | 577.6K |
| Earning Date | 11-04-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | N/A | ★ 40.79 |
| EPS | N/A | ★ 0.70 |
| Revenue | $681,539,000.00 | ★ $936,080,000.00 |
| Revenue This Year | $8.32 | $8.68 |
| Revenue Next Year | $23.36 | $8.04 |
| P/E Ratio | ★ N/A | $30.71 |
| Revenue Growth | 4.54 | ★ 7.27 |
| 52 Week Low | $29.16 | $14.21 |
| 52 Week High | $57.65 | $23.49 |
Technical Indicators
Market Signals| Indicator | SUPN | OSW |
|---|---|---|
| Relative Strength Index (RSI) | 68.51 | 61.93 |
| Support Level | $45.36 | $19.35 |
| Resistance Level | $47.26 | $21.60 |
| Average True Range (ATR) | 1.47 | 0.59 |
| MACD | 0.70 | 0.22 |
| Stochastic Oscillator | 92.77 | 91.36 |
Price Performance
Historical ComparisonAbout SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About OSW OneSpaWorld Holdings Limited
OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.